// App-Quantinova.ai

46 : Ketamine metabolites in the treatment of neuropathic pain

Researchers

Presenter

  • Lucas Stolle

Principal Investigators

  • Joseph P. Pergolizzi

  • Irving W. Wainer

Medical Centers

  • Spirify Pharma, Naples, FL, USA

  • University of Oxford, Oxford, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Pain (neuropathic)

Biomarkers

  • D-serine

Drug/Treatment

  • norketamine

  • D-serine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A